|

STP938 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Step Pharma, SAS2

Indications

  • Cancer2
  • Lymphoma, B-Cell1
  • Lymphoma, T-Cell1
  • Solid Tumor1

Denver, Colorado1 trial

A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Colorado Blood Cancer Institute

Phase 1/2

St. Petersburg, Florida1 trial

Study of STP938 in Advanced Solid Tumours

Comprehensive Hematology Oncology, LLC

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.